End-of-day quote
Shenzhen S.E.
03:30:00 01/07/2024 am IST
|
5-day change
|
1st Jan Change
|
13.11
CNY
|
+9.98%
|
|
+9.62%
|
+25.33%
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
2,873
|
19,134
|
13,208
|
11,065
|
13,869
|
-
|
-
|
Enterprise Value (EV)
1 |
2,873
|
19,134
|
13,208
|
11,065
|
13,869
|
13,869
|
13,869
|
P/E ratio
|
24.8
x
|
12.2
x
|
6.1
x
|
22.3
x
|
12.8
x
|
10.9
x
|
7.73
x
|
Yield
|
-
|
-
|
-
|
-
|
2.17%
|
2.48%
|
2.75%
|
Capitalization / Revenue
|
-
|
-
|
0.64
x
|
0.65
x
|
0.77
x
|
0.74
x
|
0.69
x
|
EV / Revenue
|
-
|
-
|
0.64
x
|
0.65
x
|
0.77
x
|
0.74
x
|
0.69
x
|
EV / EBITDA
|
-
|
-
|
3.62
x
|
5.08
x
|
5.77
x
|
5.22
x
|
3.58
x
|
EV / FCF
|
-
|
-
|
-
|
-
|
-14.7
x
|
12.7
x
|
9.56
x
|
FCF Yield
|
-
|
-
|
-
|
-
|
-6.8%
|
7.85%
|
10.5%
|
Price to Book
|
-
|
-
|
2.82
x
|
1.68
x
|
1.89
x
|
1.68
x
|
1.41
x
|
Nbr of stocks (in thousands)
|
8,97,867
|
8,97,867
|
8,97,867
|
10,57,867
|
10,57,867
|
-
|
-
|
Reference price
2 |
3.200
|
21.31
|
14.71
|
10.46
|
13.11
|
13.11
|
13.11
|
Announcement Date
|
29/04/21
|
08/04/22
|
12/03/23
|
12/04/24
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
-
|
-
|
20,713
|
17,042
|
17,932
|
18,827
|
20,025
|
EBITDA
1 |
-
|
-
|
3,646
|
2,179
|
2,404
|
2,654
|
3,875
|
EBIT
1 |
-
|
-
|
2,952
|
1,059
|
1,713
|
1,929
|
2,742
|
Operating Margin
|
-
|
-
|
14.25%
|
6.22%
|
9.55%
|
10.25%
|
13.7%
|
Earnings before Tax (EBT)
1 |
-
|
-
|
2,969
|
968.8
|
1,699
|
1,916
|
2,714
|
Net income
1 |
115.8
|
1,569
|
2,164
|
453.1
|
1,081
|
1,257
|
1,773
|
Net margin
|
-
|
-
|
10.45%
|
2.66%
|
6.03%
|
6.68%
|
8.85%
|
EPS
2 |
0.1290
|
1.748
|
2.411
|
0.4698
|
1.027
|
1.203
|
1.695
|
Free Cash Flow
1 |
-
|
-
|
-
|
-
|
-943
|
1,088
|
1,450
|
FCF margin
|
-
|
-
|
-
|
-
|
-5.26%
|
5.78%
|
7.24%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
40.99%
|
37.42%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
86.53%
|
81.78%
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
0.2850
|
0.3250
|
0.3600
|
Announcement Date
|
29/04/21
|
08/04/22
|
12/03/23
|
12/04/24
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
-
|
-
|
-
|
-943
|
1,088
|
1,450
|
ROE (net income / shareholders' equity)
|
-
|
-
|
60.8%
|
8.24%
|
14.9%
|
15%
|
17.6%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
10.7%
|
2.21%
|
5%
|
5.55%
|
7.9%
|
Assets
1 |
-
|
-
|
20,266
|
20,551
|
21,627
|
22,655
|
22,443
|
Book Value Per Share
2 |
-
|
-
|
5.210
|
6.210
|
6.930
|
7.800
|
9.300
|
Cash Flow per Share
2 |
-
|
-
|
4.300
|
1.540
|
1.770
|
1.680
|
-
|
Capex
1 |
-
|
-
|
2,203
|
1,492
|
1,374
|
1,341
|
1,447
|
Capex / Sales
|
-
|
-
|
10.64%
|
8.75%
|
7.66%
|
7.12%
|
7.22%
|
Announcement Date
|
29/04/21
|
08/04/22
|
12/03/23
|
12/04/24
|
-
|
-
|
-
|
Last Close Price
13.11
CNY Average target price
13.84
CNY Spread / Average Target +5.57% Consensus |
1st Jan change
|
Capi.
|
---|
| +25.33% | 1.91B | | +6.47% | 76.98B | | -8.70% | 42.48B | | +3.04% | 33.14B | | +13.63% | 19.02B | | +5.96% | 11.19B | | -23.74% | 9.77B | | -10.58% | 9.48B | | -1.35% | 8.79B | | -3.44% | 8.74B |
Diversified Chemicals
|